🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Improving the quality of the Global Burden of Disease tuberculosis estimates from the Institute for Health Metrics and Evaluation doi.org/10.1093/ije/dy…

Our SARS-CoV-2 environmental surveillance study is now published in The Lancet Regional Health-Southeast Asia! Read how our brilliant lab, bioinformatics and stats teams correlated SARS-COV-2 RNA conc. with reported cases in the 'sewershed': authors.elsevier.com/sd/article/S27… M Imran Nisar

New study from #Pakistan #Wastewater sampling effectively predicts an outbreak of #COVID19 in areas with low active case surveillance or poor access to care, even without a well-mapped sewage system Read more 👉 bit.ly/46Mht58

When someone talks about limited real world evidence for a particular intervention and how they intend to fill that gap, but you have published on it multiple times (with ~15k participants in 1 instance) including the same comparison they are making #MedTwitter #conferences

Our individual patient data meta-analysis shows levofloxacin exposures at current WHO-recommended doses is below the AUC target for children. Revised weight-band dosing guidelines of >20 mg/kg required. O'Donnell School of Public Health at UTSW IRD Global #MedTwitter #GlobalHealth academic.oup.com/cid/article/do…

On this #WorldTBDay2024, join us at O'Donnell School of Public Health at UTSW for a talk by Salmaan Keshavjee on TB Elimination: Challenges, Barriers, and Gaps. What can we do differently? Stop TB Partnership Harvard Medical School

Thank you Salmaan Keshavjee for the wonderful talk!

Had a great time at the @union_tblh NAR and National Tuberculosis Coalition of America meeting in Baltimore this week. Always a pleasure running into old friends, meeting new friends, and introducing new trainees to our welcoming community. BU_TIARA Boston University School of Public Health #endTB

Amazing work! This paper provides a nuanced analysis of who benefits the most from TPT and in what context. Fortunate to work with an amazing team on this. #medtwitter O'Donnell School of Public Health at UTSW

A massive effort led by Lauren Pischel, MD MSc and team. The VE of 2 dose MVA-BN is 82% against Mpox. doi.org/10.1016/j.vacc… #medtwitter #epidemiology O'Donnell School of Public Health at UTSW

Are pan-TB treatment regimens likely to drive the emergence of novel drug resistance? We investigated, in a new paper here wwwnc.cdc.gov/eid/article/30… with Emily Kendall Nick Menzies Richard White Ted Cohen Tess Ryckman London School of Hygiene & Tropical Medicine LSHTM TB Centre CMMID LSHTM TB Modelling Group

Tuberculosis preventive treatment for household contacts at health facility and community settings in Pakistan ✅ Just Accepted ✍️ Amyn A. Malik, MBBS, MPH, PhD 🔗 bit.ly/41yCNeq

Excited to share our new paper in Vaccine! We surveyed US adults on #mpox Clade Ib awareness, attitudes, and #vaccine intent. Findings: 58% would vaccinate if recommended—up from 2022—but gaps in knowledge and trust remain. Thanks to brilliant coauthors Amyn A. Malik, MBBS, MPH, PhD @saadomer3